——Dual-Enzyme Process Redefines Sustainable Pharmaceutical Manufacturing A leading biotechnology enterprise in Northwest China has commenced commercial production of Ursodeoxycholic Acid (UDCA) active pharmaceutical ingredient (API), marking the region's inaugural transition from bulk intermediates